A plain-language guide

neurofibromatosis type 1

What's known, what's still uncertain, and what's actively debated, written plainly, and built only from published medical research.

Growing map · 33 sourced statements Every statement names its source Updated 2026-08-04
Please read this first. This guide is a companion to your medical team, not a replacement, and it is not medical advice. Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet, not that it is unknown to medicine. neurofibromatosis type 1 is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind. For anything about your own situation, your clinicians hold the full picture. How this guide is built and why.

What's neurofibromatosis type 1?

Neurofibromatosis type 1 is an autosomal dominant disorder caused by loss-of-function mutations in the NF1 gene, which encodes neurofibromin, a negative regulator of the RAS/MAPK pathway. It is the most common phakomatosis, is fully penetrant but highly variable, and roughly half of cases arise de novo. Hallmark features include multiple café-au-lait macules, skinfold (axillary and inguinal) freckling, cutaneous and plexiform neurofibromas, iris Lisch nodules, optic pathway glioma, and characteristic bone changes. There is no cure; the MEK inhibitor selumetinib is an approved targeted therapy for symptomatic inoperable plexiform neurofibromas, and care otherwise centres on surveillance and managing complications.

Also indexed asOMIM:162200, MONDO:0018975
Features mapped19
Treatments mapped3
Published sources16
Last reviewed2026-08-04

Signs and symptoms

Optic nerve glioma

An optic pathway glioma is a low-grade tumor of the nerves connecting the eyes to the brain. It is one of the tumors children with the condition are watched for, since it can affect vision.

Limited evidenceSource: PMID:16134300
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:38413225, OMIM:162200
Notesplain_language confirmed from PMID:38413225 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:16134300 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Astrocytoma

Astrocytomas are tumors that grow from star-shaped support cells (astrocytes) in the brain. In NF1 they can occur, often in the midline of the brain, and these tumors generally have a good outlook.

Limited evidenceSource: PMID:16134300
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:162200
Notesplain_language confirmed from PMID:16134300 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:162200 -> PMID:16134300 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Glioma

Gliomas are tumors that arise from the supporting (glial) cells of the brain and nervous system. In NF1 they are among the tumors that can develop, alongside other changes such as skeletal differences and learning difficulties.

Limited evidenceSource: PMID:11898512
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:162200
Notesplain_language confirmed from PMID:11898512 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:162200 -> PMID:11898512 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Lisch nodules

Lisch nodules are tiny harmless growths on the iris of the eye. They do not affect vision but are a useful diagnostic sign, found with an eye examination.

Limited evidenceSource: PMID:38596211
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:38533410, OMIM:162200
Notesplain_language confirmed from PMID:38533410 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:38596211 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Malignant peripheral nerve sheath tumor

A plexiform neurofibroma can, in a minority of people, change into a cancer called a malignant peripheral nerve sheath tumor. New or rapidly growing pain, or a lump that changes, is a reason to seek prompt evaluation.

Limited evidenceSource: PMID:30724342
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40408086, OMIM:162200
Notesplain_language confirmed from PMID:40408086 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:162200 -> PMID:30724342 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Plexiform neurofibroma

Plexiform neurofibromas are larger tumors that grow along the length of a nerve. They are a common complication, can be present from birth, are often hard to remove surgically, and may cause pain or press on nearby structures.

Limited evidenceSource: PMID:40034962
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41299544, OMIM:162200
Notesplain_language confirmed from PMID:41299544 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:40034962 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Neurofibroma

Neurofibromas are soft, benign tumors that grow on nerves, usually appearing as bumps on or under the skin from later childhood onward.

Limited evidenceSource: PMID:11898512
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:39622609, OMIM:162200
Notesplain_language confirmed from PMID:39622609 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:11898512 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Tibial pseudarthrosis

A specific bone problem is tibial pseudarthrosis, where the shin bone fails to heal normally, sometimes after a fracture, and forms a false joint. It is one of the distinctive skeletal features.

Limited evidenceSource: PMID:21495174
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41185817, OMIM:162200
Notesplain_language confirmed from PMID:41185817 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:21495174 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Hydrocephalus

Hydrocephalus is a buildup of fluid in the spaces of the brain. It can occur in NF1, sometimes together with changes in the lining around the spinal cord.

Limited evidenceSource: PMID:16134300
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:162200
Notesplain_language confirmed from PMID:16134300 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:162200 -> PMID:16134300 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Specific learning disability

Learning difficulties are common in NF1 and are one of its developmental effects, separate from the tumors. Recognizing them early allows for school support.

Limited evidenceSource: PMID:11898512
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40408086, OMIM:162200
Notesplain_language confirmed from PMID:40408086 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:162200 -> PMID:11898512 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Seizure

Seizures can occur in NF1. In one hospital-based group of people with NF1, about 11 in 100 had some form of epilepsy (a tendency to recurrent seizures).

Limited evidenceSource: PMID:31443616
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:38533410, OMIM:162200
Notesplain_language confirmed from PMID:38533410 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:162200 -> PMID:31443616 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Hypertension

High blood pressure (hypertension) can occur in NF1. It may come from changes in the blood vessels themselves, which can also lead to ballooning of a vessel wall (an aneurysm).

Limited evidenceSource: PMID:16134300
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesOMIM:162200
Notesplain_language confirmed from PMID:16134300 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:162200 -> PMID:16134300 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Autosomal dominant inheritance

NF1 is inherited in an autosomal dominant pattern, so a child of an affected parent has a 1 in 2 chance of inheriting it. About half of cases instead arise from a new (de novo) gene change in someone with no family history.

Limited evidenceSource: PMID:29618358
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:39622609, OMIM:162200
Notesplain_language confirmed from PMID:39622609 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:162200 -> PMID:29618358 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Sphenoid wing dysplasia

NF1 can affect bone development. One of the distinctive bone changes is dysplasia of the sphenoid wing, a bone behind the eye.

Limited evidenceSource: PMID:21495174
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41185817, OMIM:162200
Notesplain_language confirmed from PMID:41185817 via curation 2026-06-18 [claude (tier3 curation)]. | regrounded primary OMIM:162200 -> PMID:21495174 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Scoliosis

Bone problems can occur, including scoliosis, a sideways curvature of the spine.

Limited evidenceSource: PMID:18248783
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41185817, OMIM:162200
Notesplain_language confirmed from PMID:41185817 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:18248783 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Freckling

Freckling in NF1 means clusters of small freckle-like spots, typically in skin folds such as the armpits and the groin. It is one of the characteristic features of the condition, appearing alongside cafe-au-lait macules, Lisch nodules, skeletal changes, and neurofibromas.

Limited evidenceSource: PMID:31443616
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41299544, OMIM:162200
Notesplain_language confirmed from PMID:41299544 via curation 2026-06-25 [claude-draft]. | regrounded primary OMIM:162200 -> PMID:31443616 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Inguinal freckling

Freckling in the groin (inguinal) folds is another characteristic skin sign, again in areas not exposed to the sun.

Limited evidenceSource: PMID:38596211
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41185817, OMIM:162200
Notesplain_language confirmed from PMID:41185817 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:38596211 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Multiple cafe-au-lait spots

Multiple café-au-lait spots, flat light-brown patches on the skin, are usually the earliest sign and often appear in infancy. Having six or more is one of the key diagnostic features.

Limited evidenceSource: PMID:31443616
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40719757, OMIM:162200
Notesplain_language confirmed from PMID:40719757 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:31443616 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

Axillary freckling

Freckling in the armpits is a characteristic sign. Unlike ordinary freckles it appears in skin folds that are not exposed to the sun.

Limited evidenceSource: PMID:38596211
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42196922, OMIM:162200
Notesplain_language confirmed from PMID:42196922 via curation 2026-06-14. | regrounded primary OMIM:162200 -> PMID:38596211 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26

How it is diagnosed

Neurofibromatosis, type 1

Diagnosed using: NIH diagnostic criteria (revised 2021).

Limited evidenceSource: PMID:38533410
The source text this rests on
“…revised NIH diagnostic criteria published in…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:38533410 via curation 2026-06-18
Last reviewed2026-06-18

Neurofibromatosis, type 1

Diagnosed using: NF1 genetic testing.

Limited evidenceSource: PMID:40719757
The source text this rests on
“…molecular genetic testing is usually required to confirm the…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:40719757 via curation 2026-06-25
Last reviewed2026-06-25

Neurofibromatosis, type 1

Diagnosed using: ophthalmologic examination.

Limited evidenceSource: PMID:40068833
The source text this rests on
“Optic nerve glioma poses a significant threat to vision in NF1 patients, necessitating biannual follow-up until age 6, including MRI, fundoscopy, and OCT…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:40068833 via curation 2026-06-25
Last reviewed2026-06-25

Treatment and management

What the research describes, not a recommendation. Treatment decisions belong with your clinician.

This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.

selumetinib

Selumetinib is a targeted medicine (a MEK inhibitor) that blocks the overactive growth pathway in the tumors. It is used for children with symptomatic, inoperable plexiform neurofibromas, where it can shrink the tumor and reduce pain.

Used to help with: Plexiform neurofibroma.

Limited evidenceSource: PMID:39762421
The source text this rests on
“The MEK inhibitor selumetinib induces objective responses and provides clinical benefit in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs).”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:39762421 via curation 2026-06-14
Last reviewed2026-06-14

mirdametinib

Mirdametinib is a targeted medicine (a MEK inhibitor) that blocks the overactive growth signaling driving NF1 tumors. It is approved for symptomatic plexiform neurofibromas that cannot be removed by surgery, in both children and adults.

Used to help with: Neurofibromatosis, type 1.

Limited evidenceSource: PMID:41816962
The source text this rests on
“…mirdametinib, a selective MEK1/2 inhibitor approved for the treatment of symptomatic, inoperable NF1-PNs in children and…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41816962 via curation 2026-06-25
Last reviewed2026-06-25

surgical resection

Surgery to remove tumors is one way the neurofibromas of NF1 are managed. It is not always possible, though: plexiform neurofibromas are a common complication of NF1 that are often inoperable and can come back after removal.

Used to help with: Neurofibromatosis, type 1.

Limited evidenceSource: PMID:41299544
The source text this rests on
“Plexiform neurofibromas (PN), a common complication of NF1, are often inoperable and prone to…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41299544 via curation 2026-06-25
Last reviewed2026-06-25

How to read the evidence labels

Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.

Where this comes from

This guide is built from 16 published source(s). Every claim above links back to one of them. Click any source ID to read the original on PubMed.

OMIM:162200 · Orphanet/HPO annotations for Neurofibromatosis, type 1
PMID:11898512 · Diagnosis and management of neurofibromatosis type 1.
PMID:16134300 · [Imaging features of neurofibromatosis type 1].
PMID:18248783 · Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1).
PMID:21495174 · The musculoskeletal phenotype of the RASopathies.
PMID:29618358 · Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
PMID:30724342 · Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
PMID:31443616 · Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
PMID:38533410 · Epidemiology and Outcomes of Neurofibromatosis Type 1 (NF-1): Multicenter Tertiary Experience.
PMID:38596211 · Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype.
PMID:39762421 · Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
PMID:40034962 · Malignant Peripheral Nerve Sheath Tumor (MPNST) Arising from Orbital Plexiform Neurofibroma in a Small Child With Neurofibromatosis Type 1.
PMID:40068833 · Longitudinal clinical characteristics of patients with neurofibromatosis type 1.
PMID:40719757 · Long-read sequencing for NF1 gene analysis: enhancing diagnostic accuracy for Neurofibromatosis type 1.
PMID:41299544 · Clinical characteristics and healthcare burden of neurofibromatosis type 1 in Saudi Arabia: a single centre experience.
PMID:41816962 · Mirdametinib in symptomatic neurofibromatosis type 1 plexiform neurofibromas.

Take it further

Printed, source-linked documents built from this condition's graph — ready to bring to an appointment or attach to a coverage request. Every claim carries its published source, the same as this guide.